IceCure Medical Ltd.(ICCM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ICCM IceCure Medical Ltd.

Not Yet Opened 12-20 16:00:00 EST

1.12

-0.03

-2.61%

盘后1.11

-0.01-0.89%

17:55 EST

High1.19	Low1.11	Vol398.82K
Open1.15	D1 Closing1.15	Amplitude6.96%
Mkt Cap61.35M	Tradable Cap30.60M	Total Shares54.78M
T/O456.48K	T/O Rate1.46%	Tradable Shares27.32M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ICCM","market":"US","secType":"STK","nameCN":"IceCure Medical Ltd.","latestPrice":1.12,"timestamp":1734728400000,"preClose":1.15,"halted":0,"volume":398824,"hourTrading":{"tag":"盘后","latestPrice":1.11,"preClose":1.12,"latestTime":"17:55 EST","volume":6048,"amount":6713.5718,"timestamp":1734735326229},"delay":0,"floatShares":27317821,"shares":54778879,"eps":-0.286454,"marketStatus":"Not Yet Opened","change":-0.03,"latestTime":"12-20 16:00:00 EST","open":1.15,"high":1.19,"low":1.11,"amount":456478.236734,"amplitude":0.069565,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.286454,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1734944400000},"marketStatusCode":0,"adr":0,"listingDate":1629950400000,"exchange":"NASDAQ","adjPreClose":1.15,"preHourTrading":{"tag":"盘前","latestPrice":1.155,"preClose":1.15,"latestTime":"09:29 EST","volume":1652,"amount":1915.380012,"timestamp":1734704956585},"postHourTrading":{"tag":"盘后","latestPrice":1.11,"preClose":1.12,"latestTime":"17:55 EST","volume":6048,"amount":6713.5718,"timestamp":1734735326229},"volumeRatio":0.5503999408300757},"requestUrl":"/m/hq/s/ICCM/wiki","defaultTab":"wiki","newsList":[{"id":"2491691563","title":"Data on IceCure's ProSense® Cryoablation for Low-Risk Breast Cancer Presented at Radiological Society of North America's 2024 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2491691563","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491691563?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:30","pubTimestamp":1734355800,"startTime":"0","endTime":"0","summary":"ICE3 trial results presented by ICE3 Co-Principal Investigator Dr. KennethTomkovich. FDA Advisory Panel voted in favor of IceCure's ProSense cryoablation benefit-risk profile in early-stage low risk breast cancer in Nov. 2025. FDA's marketing authorization decision expected in Q1, 2025. Dr. Tomkovich commented, \"The significance of the ICE3 results in the field of radiology, especially among breast radiologists, cannot be overstated. As the largest study of its kind, ICE3 provides crucial data that can support the shift towards the de-escalation of breast cancer care with cryoablation as a less invasive procedure, enabling the cohort of patients included in ICE3 to have a safe and effective option to surgical lumpectomy.\". \"ProSense's ICE3 results are gaining increasing prominence across a range of medical specialty conferences globally, as well as through prominent peer reviewed journals. This is critical support for market adoption leading up to the expected decision of the U.S. Food","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gLojd3jfLjCdwgJQFQQ3kg--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gLojd3jfLjCdwgJQFQQ3kg--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/data-icecures-prosense-cryoablation-low-133000696.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/data-icecures-prosense-cryoablation-low-133000696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","ICCM"],"gpt_icon":0},{"id":"2489543874","title":"IceCure Medical’s Cryoablation Success in Kidney Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2489543874","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489543874?lang=en_us&edition=fundamental","pubTime":"2024-12-05 21:57","pubTimestamp":1733407030,"startTime":"0","endTime":"0","summary":"Icecure Medical (ICCM) has released an update. IceCure Medical’s ProSense® Cryoablation technology shows promise in treating kidney tumors with an ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecure-medicals-cryoablation-success-in-kidney-tumors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecure-medicals-cryoablation-success-in-kidney-tumors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","ICCM"],"gpt_icon":0},{"id":"2489459299","title":"BRIEF-IceCure's ProSense® Cryoablation Safe and Effective in Destruction of Kidney Tumors with 88.7% Recurrence-Free Rate Based on Interim ICESECRET Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2489459299","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489459299?lang=en_us&edition=fundamental","pubTime":"2024-12-05 21:36","pubTimestamp":1733405819,"startTime":"0","endTime":"0","summary":"Dec 5 (Reuters) - Icecure Medical Ltd   :   * ICECURE'S PROSENSE CRYOABLATION SAFE, EFFECTIVE IN KIDNEY TUMORS DESTRUCTION WITH 88.7% RECURRENCE-FREE RATE BASED ON INTERIM ICESECRET STUDY RESULTSSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICCM","BK4082"],"gpt_icon":0},{"id":"2489451825","title":"IceCure Medical’s ProSense cryoablation shows efficacy in kidney tumor study","url":"https://stock-news.laohu8.com/highlight/detail?id=2489451825","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489451825?lang=en_us&edition=fundamental","pubTime":"2024-12-05 21:35","pubTimestamp":1733405749,"startTime":"0","endTime":"0","summary":"IceCure Medical (ICCM) announced interim results from the company’s ICESECRET study of cryoablation for patients with small renal masses who cannot...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/icecure-medicals-prosense-cryoablation-shows-efficacy-in-kidney-tumor-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/icecure-medicals-prosense-cryoablation-shows-efficacy-in-kidney-tumor-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICCM","BK4082"],"gpt_icon":0},{"id":"2489845923","title":"Icecure's Prosense Cryoablation Safe, Effective in Kidney Tumors Destruction With 88.7% Recurrence-Free Rate Based on Interim Icesecret Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2489845923","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489845923?lang=en_us&edition=fundamental","pubTime":"2024-12-05 21:35","pubTimestamp":1733405740,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241205:nFWN3N60VL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ICCM","BK4082"],"gpt_icon":0},{"id":"2486072188","title":"Icecure Medical’s Strategic Position and Growth Potential Justifies Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2486072188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486072188?lang=en_us&edition=fundamental","pubTime":"2024-11-28 05:05","pubTimestamp":1732741514,"startTime":"0","endTime":"0","summary":"Anthony Vendetti, an analyst from Maxim Group, reiterated the Buy rating on Icecure Medical (ICCM – Research Report). The associated price target r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/icecure-medicals-strategic-position-and-growth-potential-justifies-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/icecure-medicals-strategic-position-and-growth-potential-justifies-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICCM","BK4082"],"gpt_icon":0},{"id":"2486085448","title":"Icecure Medical Price Target Maintained With a $2.50/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2486085448","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486085448?lang=en_us&edition=fundamental","pubTime":"2024-11-28 02:05","pubTimestamp":1732730700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ICCM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 27, 2024 13:05 ET (18:05 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICCM"],"gpt_icon":0},{"id":"2486046871","title":"Icecure Medical: Strong Growth and Regulatory Momentum Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2486046871","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486046871?lang=en_us&edition=fundamental","pubTime":"2024-11-28 00:35","pubTimestamp":1732725312,"startTime":"0","endTime":"0","summary":"Icecure Medical (ICCM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yi Chen from H.C. Wa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/icecure-medical-strong-growth-and-regulatory-momentum-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/icecure-medical-strong-growth-and-regulatory-momentum-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","ICCM"],"gpt_icon":0},{"id":"2486842846","title":"IceCure Medical Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2486842846","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486842846?lang=en_us&edition=fundamental","pubTime":"2024-11-27 18:32","pubTimestamp":1732703560,"startTime":"0","endTime":"0","summary":"NasdaqCM:ICCM Earnings and Revenue Growth November 27th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 6.6%. Earnings per share  exceeded analyst estimates.Looking ahead, revenue is forecast to grow 58% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US.The company's shares are up 29% from a week ago.It is worth noting though that we have found 4 warning signs for IceCure Medical that you need to take into consideration.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icecure-medical-third-quarter-2024-103240862.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ICCM"],"gpt_icon":0},{"id":"2486278898","title":"IceCure Medical Sees Strong Growth Amid ProSense® Adoption","url":"https://stock-news.laohu8.com/highlight/detail?id=2486278898","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486278898?lang=en_us&edition=fundamental","pubTime":"2024-11-27 11:55","pubTimestamp":1732679723,"startTime":"0","endTime":"0","summary":"Icecure Medical Ltd. ( ($ICCM) ) has released its Q3 earnings. Here is a breakdown of the information Icecure Medical Ltd. presented to its investo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecure-medical-sees-strong-growth-amid-prosense-adoption?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecure-medical-sees-strong-growth-amid-prosense-adoption?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICCM","BK4082"],"gpt_icon":0},{"id":"2486880198","title":"IceCure Medical price target raised to $4.60 from $4.16 at Brookline","url":"https://stock-news.laohu8.com/highlight/detail?id=2486880198","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486880198?lang=en_us&edition=fundamental","pubTime":"2024-11-27 02:50","pubTimestamp":1732647010,"startTime":"0","endTime":"0","summary":"Brookline raised the firm’s price target on IceCure Medical (ICCM) to $4.60 from $4.16 and keeps a Buy rating on the shares after Q3 results the fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/icecure-medical-price-target-raised-to-4-60-from-4-16-at-brookline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/icecure-medical-price-target-raised-to-4-60-from-4-16-at-brookline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BRKL","ICCM"],"gpt_icon":0},{"id":"2486883914","title":"IceCure Medical Ltd. (ICCM) Reports Q3 Loss, Misses Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2486883914","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486883914?lang=en_us&edition=fundamental","pubTime":"2024-11-26 22:40","pubTimestamp":1732632002,"startTime":"0","endTime":"0","summary":"IceCure Medical Ltd.  came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -14.29%. A quarter ago, it was expected that this company would post a loss of $0.07 per share when it actually produced a loss of $0.06, delivering a surprise of 14.29%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.IceCure Medical , which belongs to the Zacks Medical Services industry, posted revenues of $0.66 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 5.43%. This compares to year-ago revenues of $0.33 million. The company has topped consensus revenue estimates just once over the last four quarters.Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/26ddEdIk.0DefsBmi91u3Q--~B/aD01OTg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/26ddEdIk.0DefsBmi91u3Q--~B/aD01OTg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icecure-medical-ltd-iccm-reports-144002418.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ICCM"],"gpt_icon":0},{"id":"2486061080","title":"IceCure Medical GAAP EPS of $0.22 , revenue of $2.41M","url":"https://stock-news.laohu8.com/highlight/detail?id=2486061080","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486061080?lang=en_us&edition=fundamental","pubTime":"2024-11-26 22:05","pubTimestamp":1732629949,"startTime":"0","endTime":"0","summary":"IceCure Medical press release  (NASDAQ:ICCM): 9M GAAP EPS of $0.22\nRevenue of $2.41M.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4335255-icecure-medical-gaap-eps-of-022-revenue-of-241m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["ICCM"],"gpt_icon":0},{"id":"2486005597","title":"IceCure Medical’s Promising Growth and FDA Anticipation","url":"https://stock-news.laohu8.com/highlight/detail?id=2486005597","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486005597?lang=en_us&edition=fundamental","pubTime":"2024-11-26 21:57","pubTimestamp":1732629450,"startTime":"0","endTime":"0","summary":"Icecure Medical (ICCM) has released an update. IceCure Medical has reported a notable 36% sales increase in the first nine months of 2024, driven b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecure-medicals-promising-growth-and-fda-anticipation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecure-medicals-promising-growth-and-fda-anticipation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICCM","BK4082"],"gpt_icon":0},{"id":"2486100808","title":"IceCure Medical reports 36% sales growth in first nine months of 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2486100808","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486100808?lang=en_us&edition=fundamental","pubTime":"2024-11-26 21:35","pubTimestamp":1732628117,"startTime":"0","endTime":"0","summary":"IceCure Medical (ICCM) reported financial results as of and for the nine months ended September 30. Sales of ProSense consoles and disposable probe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/icecure-medical-reports-36-sales-growth-in-first-nine-months-of-2024?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/icecure-medical-reports-36-sales-growth-in-first-nine-months-of-2024?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICCM"],"gpt_icon":0},{"id":"2486083770","title":"Press Release: IceCure Medical Reports 36% Sales Growth in the First Nine Months of 2024 Driven by Global Adoption of ProSense(R) Cryoablation","url":"https://stock-news.laohu8.com/highlight/detail?id=2486083770","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486083770?lang=en_us&edition=fundamental","pubTime":"2024-11-26 21:30","pubTimestamp":1732627800,"startTime":"0","endTime":"0","summary":"IceCure Medical Reports 36% Sales Growth in the First Nine Months of 2024 Driven by Global Adoption of ProSense Cryoablation. FDA Marketing Authorization Decision on Early Stage-Low Risk Breast Cancer Expected in Q1 2025. On November 7, 2024, the U.S. Food and Drug Administration's  Medical Device Advisory Committee Panel  voted in favor of ProSense's benefit-risk profile in early-stage low risk breast cancer.\"While our efforts have remained focused on the U.S. marketing authorization for ProSense in early-stage breast cancer, the impressive 36% sales growth for the first nine months ended September 30, 2024, compared to the same period last year, demonstrates our commitment to working with our global partners to accelerate the adoption and increase the utilization of ProSense,\" stated IceCure Medical's CEO, Eyal Shamir. \"As we near the end of 2024, it goes without saying that it is shaping up to be a transformative year for IceCure. We successfully completed the ICE3 trial and publish","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","ICCM"],"gpt_icon":0},{"id":"2486087505","title":"IceCure Medical’s Cryoablation Innovation Gains Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2486087505","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486087505?lang=en_us&edition=fundamental","pubTime":"2024-11-25 22:10","pubTimestamp":1732543833,"startTime":"0","endTime":"0","summary":"Icecure Medical (ICCM) has released an update. IceCure Medical has achieved a significant milestone with a Notice of Allowance from Japan’s Patent ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecure-medicals-cryoablation-innovation-gains-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecure-medicals-cryoablation-innovation-gains-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","ICCM"],"gpt_icon":0},{"id":"2486624084","title":"BRIEF-Icecure's Next-Generation Multiprobe Cryoablation Technology Issued Notice Of Allowance From Japan's Patent Office","url":"https://stock-news.laohu8.com/highlight/detail?id=2486624084","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486624084?lang=en_us&edition=fundamental","pubTime":"2024-11-25 21:48","pubTimestamp":1732542508,"startTime":"0","endTime":"0","summary":"BRIEF-Icecure's Next-Generation Multiprobe Cryoablation Technology Issued Notice Of Allowance From Japan's Patent OfficeNov 25 (Reuters) - Icecure Medical Ltd ICCM.O:ICECURE'S NEXT-GENERATION MULTIPRO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241125:nFWN3MW0V1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICCM","BK4082"],"gpt_icon":0},{"id":"2486708480","title":"IceCure Medical receives Notice of Allowance from Japan’s Patent Office","url":"https://stock-news.laohu8.com/highlight/detail?id=2486708480","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486708480?lang=en_us&edition=fundamental","pubTime":"2024-11-25 21:35","pubTimestamp":1732541758,"startTime":"0","endTime":"0","summary":"IceCure Medical (ICCM) announced it has received a Notice of Allowance from the Japan Patent Office for its invention titled ‘Cryogenic System with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/icecure-medical-receives-notice-of-allowance-from-japans-patent-office?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/icecure-medical-receives-notice-of-allowance-from-japans-patent-office?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICCM","BK4082"],"gpt_icon":0},{"id":"2486816120","title":"Icecure Medical Ltd:  Terumo Corporation Plans to File for Regulatory Approval of Prosense for Breast Cancer in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2486816120","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486816120?lang=en_us&edition=fundamental","pubTime":"2024-11-25 21:30","pubTimestamp":1732541417,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241125:nFWN3MW0V1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","ICCM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.icecure-medical.com","stockEarnings":[{"period":"1week","weight":0.0467},{"period":"1month","weight":0.8589},{"period":"3month","weight":0.75},{"period":"6month","weight":0.5226},{"period":"1year","weight":0.1886},{"period":"ytd","weight":0.0467}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0403},{"period":"6month","weight":0.0857},{"period":"1year","weight":0.2506},{"period":"ytd","weight":0.2437}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.034786},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.052093},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.02219},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.004073},{"month":5,"riseRate":0,"avgChangeRate":-0.132422},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.098239},{"month":7,"riseRate":0.666667,"avgChangeRate":0.014625},{"month":8,"riseRate":0,"avgChangeRate":-0.095675},{"month":9,"riseRate":0,"avgChangeRate":-0.232692},{"month":10,"riseRate":0.5,"avgChangeRate":0.131383},{"month":11,"riseRate":0.5,"avgChangeRate":-0.024268},{"month":12,"riseRate":0.5,"avgChangeRate":0.126609}],"exchange":"NASDAQ","name":"IceCure Medical Ltd.","nameEN":"IceCure Medical Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IceCure Medical Ltd.(ICCM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest IceCure Medical Ltd.(ICCM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"IceCure Medical Ltd.,ICCM,IceCure Medical Ltd.股票,IceCure Medical Ltd.股票老虎,IceCure Medical Ltd.股票老虎国际,IceCure Medical Ltd.行情,IceCure Medical Ltd.股票行情,IceCure Medical Ltd.股价,IceCure Medical Ltd.股市,IceCure Medical Ltd.股票价格,IceCure Medical Ltd.股票交易,IceCure Medical Ltd.股票购买,IceCure Medical Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IceCure Medical Ltd.(ICCM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest IceCure Medical Ltd.(ICCM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction